Valeant Pharma (VRX) Adds to Recent Gains

August 24, 2016 10:38 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Valeant Pharma (NYSE: VRX) adding to recent gains on trader talk management will be meeting with the Morgan Stanley analyst that upgraded the stock last week. Shares are up 4.4%.

Shares of VRX are up nearly 23% since the upgrade from David Risinger on August 17.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Trader Talk

Related Entities

Morgan Stanley

Add Your Comment